Suven Life Sciences Limited — Important, 29-10-2024: Financial Result Updates

Suven Life Sciences Limited reported its unaudited financial results for the quarter and half-year ending September 30, 2024. The company experienced a net loss, with significant investments in R&D continuing. Key developments include ongoing clinical trials for multiple drug candidates and the granting of six new patents across various regions. The financial results were reviewed and approved by the Board of Directors during a recent meeting. For further details, visit their website.